English Polski
Vol 22, No 1-2 (2020)
Case report
Published online: 2022-01-18

open access

Page views 2811
Article views/downloads 869
Get Citation

Connect on Social Media

Connect on Social Media

Leczenie wewnątrznaczyniowe tętniaka rozwarstwiającego aorty piersiowo-brzusznej w przebiegu zespołu Marfana

Wiktoria Kuczmik1, Maria Stec1, Agata Suleja1, Wacław Kuczmik2
Chirurgia Polska 2020;22(1-2):29-34.

Abstract

U chorych z zespołem Marfana często obserwuje się schorzenia naczyniowe. Szczególnie dużym wyzwaniem
dla współczesnej medycyny są rozwarstwienie i tętniak aorty. W niniejszej pracy przedstawiono
przypadek chorego z rozwarstwiającym tętniakiem aorty piersiowo-brzusznej, z powodzeniem leczonego
metodami wewnątrznaczyniowymi.

Article available in PDF format

View PDF (Polish) Download PDF file

References

  1. Gatzoulis MA, Webb GD, Daubeney PEF. Ed.: Diagnosis and Management of Adult Congenital Heart Disease. Elsevier Ltd. ; 2011.
  2. Groth KA, Hove H, Kyhl K, et al. Prevalence, incidence, and age at diagnosis in Marfan Syndrome. Orphanet J Rare Dis. 2015; 10: 153.
  3. Wu Y, Sun H, He Y, et al. A novel intron mutation in FBN-1 gene identified in a pregnant woman with Marfan syndrome. Hereditas. 2021; 158(1): 6.
  4. Al-Mohamad H, Stout K, Bolling T, et al. A Case of an Abdominal Aortic Dissection in a Hemodynamically Stable Marfan Syndrome Patient Presenting without Pain. Case Rep Cardiol. 2020; 2020: 1704150.
  5. Pepe G, Giusti B, Sticchi E, et al. Marfan syndrome: current perspectives. Appl Clin Genet. 2016; 9: 55–65.
  6. Loeys BL, Dietz HC, Braverman AC, et al. The revised Ghent nosology for the Marfan syndrome. J Med Genet. 2010; 47(7): 476–485.
  7. Ludzia M, Smreczyńska-Wierzbicka E, Werner B. Diagnostic and therapeutic considerations in patients with Marfan syndrome. Nowa Pediatria. 2018; 22: 27–31.
  8. Baumgartner H, De Backer J, Baumgartner H, et al. ESC Scientific Document Group. 2020 ESC Guidelines for the management of adult congenital heart disease. Eur Heart J. 2021; 42(6): 563–645.
  9. Mommertz G, Sigala F, Langer S, et al. Thoracoabdominal aortic aneurysm repair in patients with marfan syndrome. Eur J Vasc Endovasc Surg. 2008; 35(2): 181–186.
  10. Spanos K, Kölbel T, Kubitz J, et al. Risk of spinal cord ischemia after fenestrated or branched endovascular repair of complex aortic aneurysms. J Vasc Surg. 2019; 69(2): 357–366.
  11. Fleck T, Hutschala D, Tschernich H, et al. Stent graft placement of the thoracoabdominal aorta in a patient with Marfan syndrome. J Thorac Cardiovasc Surg. 2003; 125(6): 1541–1543.
  12. Waterford SD, Moon MR. Stent grafting in Marfan syndrome? We are not convinced. J Thorac Cardiovasc Surg. 2018; 156(5): 1773–1775.
  13. Pellenc Q, Girault A, Roussel A, et al. Optimising Aortic Endovascular Repair in Patients with Marfan Syndrome. Eur J Vasc Endovasc Surg. 2020; 59(4): 577–585.
  14. Harrison SC, Agu O, Harris PL, et al. Elective sac perfusion to reduce the risk of neurologic events following endovascular repair of thoracoabdominal aneurysms. J Vasc Surg. 2012; 55(4): 1202–1205.
  15. Jayia P, Constantinou J, Hamilton H, et al. Temporary Perfusion Branches to Decrease Spinal Cord Ischemia in the Endovascular Treatment of Thoraco-Abdominal Aortic Aneurysms. AORTA. 2018; 03(02): 56–60.